[PRESS RELEASE] MIGVAX’S SUBUNIT ORAL COVID-19 VACCINE PRECLINICAL TRIAL DEMONSTRATES EFFECTIVITY AS A BOOSTER
Qiryat Shmona, Israel, June 10, 2021: MigVax Ltd., a startup company developing an oral subunit vaccine against COVID-19, today announced ...